 Cohorts of 3-6 patients receive escalating doses of docetaxel and temozolomide until the maximum tolerated dose MTD is determined. The MTD is defined as the dose preceding that at which at least 2 of 3 or 2 of 6 patients experience dose-limiting toxicity. A total of 6 patients receive treatment at the MTD. 